Medicare Enrolled

Dr. Anna Szafran-Swietlik, M.D.

Endocrinology · Hudson, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
14100 FIVAY RD, Hudson, FL 34667
7278697822
In practice since 2009 (16 years)
NPI: 1780815340 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Szafran-Swietlik from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Szafran-Swietlik? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Szafran-Swietlik

Dr. Anna Szafran-Swietlik is an endocrinology in Hudson, FL, with 16 years in practice. Based on federal Medicare data, Dr. Szafran-Swietlik performed 3,847 Medicare services across 1,142 unique beneficiaries.

Between the years covered by Open Payments, Dr. Szafran-Swietlik received a total of $15,108 from 58 pharmaceutical and/or device companies across 716 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Szafran-Swietlik is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 17% volume in FL$ $15,108 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,847
Medicare services
Top 17% in FL for endocrinology
1,142
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~240 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)2,040$18$30
Office visit, established patient (30-39 min)610$90$214
Blood glucose (sugar) test performed by hand-held instrument361$3$9
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report160$26$86
Office visit, established patient (20-29 min)146$64$146
Ultrasound scan of head and neck soft tissue128$80$244
Office visit, established patient, complex (40-54 min)99$136$287
New patient office visit (45-59 min)94$116$333
Drug injection, under skin or into muscle73$10$51
Fine needle aspiration biopsy using ultrasound guidance, first growth46$107$282
New patient office visit, complex (60-74 min)38$157$412
Diabetes outpatient self-management training services, individual, per 30 minutes32$41$105
Fine needle aspiration biopsy using ultrasound guidance, each additional growth20$49$210
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,108
Total received (2018-2024)
Avg $2,158/year across 7 years
Top 23% in FL for endocrinology
58
Companies
716
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,108 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,045
2023
$2,633
2022
$2,595
2021
$1,476
2020
$2,290
2019
$1,808
2018
$2,261

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$2,329
Medtronic MiniMed, Inc.
$1,852
Amgen Inc.
$1,472
Lilly USA, LLC
$1,152
Corcept Therapeutics
$767
AstraZeneca Pharmaceuticals LP
$552
Radius Health, Inc.
$522
SANOFI-AVENTIS U.S. LLC
$522
Boehringer Ingelheim Pharmaceuticals, Inc.
$513
Xeris Pharmaceuticals, Inc.
$474
Bayer Healthcare Pharmaceuticals Inc.
$463
Insulet Corporation
$372
RECORDATI_RARE_DISEASES_INC.
$327
Bayer HealthCare Pharmaceuticals Inc.
$310
Dexcom, Inc.
$301
Amneal Pharmaceuticals LLC
$275
Merck Sharp & Dohme Corporation
$271
Medtronic, Inc.
$216
Valeritas, Inc.
$191
IBSA Pharma Inc.
$161
Amryt Pharma Holdings Ltd
$159
Lexicon Pharmaceuticals, Inc.
$138
Amarin Pharma Inc.
$117
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$114
PFIZER INC.
$106
Novartis Pharmaceuticals Corporation
$103
Mannkind Corporation
$91
Abbott Laboratories
$88
Zealand Pharma US, Inc.
$84
Kyowa Kirin, Inc.
$83
AbbVie Inc.
$77
Nevro Corp.
$74
Companion Medical, Inc.
$70
BETA BIONICS, INC.
$65
Horizon Therapeutics plc
$62
ABBVIE INC.
$61
LIFESCAN, INC.
$56
MannKind Corporation
$49
Tandem Diabetes Care, Inc.
$44
Ipsen Biopharmaceuticals, Inc
$39
Merck Sharp & Dohme LLC
$35
Esperion Therapeutics, Inc.
$30
AbbVie, Inc.
$29
Neurocrine Biosciences, Inc.
$29
LifeScan, Inc.
$28
Shire North American Group Inc
$25
EUSA Pharma (US) LLC
$25
Renalytix AI, Inc.
$23
CeQur Corporation
$23
DEXCOM, INC.
$22
Astellas Pharma US Inc
$18
Regeneron Healthcare Solutions, Inc.
$16
Kowa Pharmaceuticals America, Inc.
$16
Orexigen Therapeutics, Inc.
$15
VIVUS LLC
$14
Antares Pharma, Inc.
$14
Janssen Pharmaceuticals, Inc
$12
Strongbridge US INC.
$11
Top 3 companies account for 37.4% of total payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BASAGLAR · BRILINTA · CONTRAVE · CREON · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ENTRESTO · EVENITY · FARXIGA · FIASP · FORTEO · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · ISTURISA · InPen · Inpefa · JANUVIA · JARDIANCE · KEVEYIS · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · Korlym · LEQVIO · LICART · LOKELMA · Livalo · MACRILEN · MINIMED 780G · MOUNJARO · MYALEPT · MYCAPSSA · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · Norditropin · ONETOUCH VERIO FLEX · Omnia · Omnipod · OneTouch · Ozempic · PRALUENT ALIROCUMAB INJECTION · Prolia · QSYMIA · RAYOS · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLUJAN · SYNTHROID · Saxenda · Senza · Somatuline Depot · Sylvant · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZEPBOUND · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $393 per 100 Medicare services performed
Looking for a endocrinology in Hudson?
Compare endocrinologys in the Hudson area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
26
Per 100K population
4.4
County median income
$67,384
Nearest hospital
HCA FLORIDA BAYONET POINT HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Szafran-Swietlik is a clinical cardiology specialist, with above-average Medicare volume (top 17% in FL), and low-engagement industry engagement, with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Szafran-Swietlik experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Szafran-Swietlik performed 2,040 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Szafran-Swietlik receive payments from pharmaceutical companies?
Yes. Dr. Szafran-Swietlik received a total of $15,108 from 58 companies across 716 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Szafran-Swietlik's costs compare to other endocrinologys in Hudson?
Dr. Szafran-Swietlik's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Szafran-Swietlik) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →